SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on August 17, 2018, reporting an event that occurred on August 13, 2018. The company is incorporated in Delaware and operates under the ticker symbol "AMDA" on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
On August 13, 2018, the company received a notice from the Nasdaq Listing Qualifications Department stating that the bid price of its common stock had closed below the minimum $1.00 per share requirement for 30 consecutive trading days, violating Listing Rule 5550(a)(2). This notice does not result in immediate delisting, and trading continues uninterrupted.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The company has until February 11, 2019, to regain compliance with the minimum bid price requirement.
- Secondary Compliance Period: If compliance is not met by the initial deadline, the company may be afforded a second 180-day period. Qualification for this period requires meeting the market value of publicly held shares and all other initial listing standards, except the bid price requirement.
- Remedial Actions: Management intends to monitor the stock price and consider available options to resolve the deficiency, which may include implementing a reverse stock split.
- Risks: Failure to regain compliance could result in delisting from the Nasdaq Capital Market.
Key Facts for Investor Verification
- Verify the current closing bid price of AMDA stock to assess proximity to the $1.00 threshold.
- Monitor the company's announcements regarding the potential implementation of a reverse stock split.
- Check for any subsequent correspondence from Nasdaq regarding the status of the compliance period.
- Review the company's market value of publicly held shares to determine eligibility for a second compliance period if needed.